{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:41:55Z","timestamp":1794062515795,"version":"4.8.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.07.073","type":"journal-article","created":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T06:00:47Z","timestamp":1407304847000},"page":"5390-5398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":235,"title":["The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety"],"prefix":"10.1016","volume":"32","author":[{"given":"Michael M.","family":"McNeil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Gee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Belongia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Naleway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad B.","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"DeStefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.07.073_bib0005","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Historical comparisons of morbidity and mortality for vaccine preventable diseases in the United States","volume":"298","author":"Roush","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0010","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsa0806477","article-title":"Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases","volume":"360","author":"Omer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0015","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.99.6.765","article-title":"Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring","volume":"99","author":"Chen","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00128072-200002040-00004","article-title":"Safety of routine childhood vaccinations: an epidemiological review","volume":"2","author":"Chen","year":"2000","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0025","first-page":"43","article-title":"Adverse events following immunization","volume":"34","author":"Centers for Disease Control and Prevention","year":"1985","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0030","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0035","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127 (Suppl. 1)","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0040","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1056\/NEJMoa071434","article-title":"Early thimerosal exposure and neuropsychological outcomes at 7 and 10 years","volume":"357","author":"Thompson","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0045","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.ede.0000155506.05636.a4","article-title":"Active surveillance of vaccine safety: a system to detect early signs of adverse events","volume":"16","author":"Davis","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0050","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MLR.0b013e3180616c0a","article-title":"Real-time vaccine safety surveillance for the early detection of adverse events","volume":"45 (Suppl. 2)","author":"Lieu","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/aje\/kwp345","article-title":"Near real time surveillance for influenza vaccine safety: proof of concept in the Vaccine Safety Datalink Project","volume":"171","author":"Greene","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0060","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.vaccine.2012.01.027","article-title":"Signal identification and evaluation for risk of febrile seizure in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010\u20132011","volume":"30","author":"Tse","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0b013e3181af8605","article-title":"Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine","volume":"29","author":"Belongia","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0070","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.2012.97","article-title":"Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants","volume":"307","author":"Shui","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0075","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1016\/j.vaccine.2011.08.106","article-title":"Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink","volume":"29","author":"Gee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0080","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles\u2013mumps\u2013rubella\u2013varicella combination vaccine and the risk of febrile seizures","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"issue":"RR03","key":"10.1016\/j.vaccine.2014.07.073_bib0085","first-page":"1","article-title":"Use of combination measles, mumps, rubella, and varicella vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Marin","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amepre.2011.04.004","article-title":"H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink Project","volume":"41","author":"Lee","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0095","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/aje\/kws197","article-title":"Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009\u20132010","volume":"175","author":"Yih","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0100","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1377\/hlthaff.2012.0104","article-title":"Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance","volume":"31","author":"Salmon","year":"2012","journal-title":"Health Aff (Millwood)"},{"issue":"October 1\u2013November 24","key":"10.1016\/j.vaccine.2014.07.073_bib0105","first-page":"1351","article-title":"Safety of influenza A (H1N1) 2009 monovalent vaccines\u2014United States","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/07474946.2011.539924","article-title":"A maximized sequential probability ratio test for drug and vaccine safety surveillance","volume":"30","author":"Kulldorff","year":"2011","journal-title":"Seq Anal"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0115","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/sim.3780","article-title":"A conditional maximized sequential probability ratio test for pharmacovigilance","volume":"29","author":"Li","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/aje\/kws317","article-title":"Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study","volume":"177","author":"Nelson","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0125","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.vaccine.2013.03.040","article-title":"Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children","volume":"31","author":"Tseng","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0130","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/aje\/kws011","article-title":"Immunization and Bell's palsy in children: a case-centered analysis","volume":"175","author":"Rowhani-Rahbar","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cit222","article-title":"Lack of association of Guillain\u2013Barr\u00e9 Syndrome with vaccinations","volume":"57","author":"Baxter","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1542\/peds.2010-0309","article-title":"Prenatal and infant exposure to thimerosal from vaccine and immunoglobulins and risk of autism","volume":"126","author":"Price","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/AOG.0b013e318279f56f","article-title":"Trivalent inactivated influenza vaccine and spontaneous abortion","volume":"121","author":"Irving","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0150","series-title":"The childhood immunization schedule and safety: stakeholder concerns, scientific evidence, and future studies","year":"2013"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1001\/jamapediatrics.2013.502","article-title":"A population-based cohort study of undervaccination in 8 managed care organizations across the United States","volume":"167","author":"Glanz","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0160","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamapediatrics.2013.2745","article-title":"Effect of age on risk of fever and seizures following immunization with measles-containing vaccines in children","volume":"167","author":"Rowhani-Rhabar","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0165","doi-asserted-by":"crossref","first-page":"e1492","DOI":"10.1542\/peds.2013-3429","article-title":"Timely versus delayed early childhood vaccination and seizures","volume":"133","author":"Hambidge","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0170","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamapediatrics.2013.2353","article-title":"Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age","volume":"167","author":"Glanz","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0175","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2796.2011.02474.x","article-title":"Safety of zoster vaccine in adults from a large managed care cohort: a Vaccine Safety Datalink study","volume":"271","author":"Tseng","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0180","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archpediatrics.2011.112","article-title":"Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the Vaccine Safety Datalink","volume":"165","author":"Glanz","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0185","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/cid\/cis871","article-title":"Safety of tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population","volume":"56","author":"Tseng","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0190","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archpedi.155.3.354","article-title":"Measles\u2013mumps\u2013rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case\u2013control study from the Vaccine Safety Datalink project","volume":"155","author":"Davis","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0195","doi-asserted-by":"crossref","first-page":"E112","DOI":"10.1542\/peds.108.6.e112","article-title":"Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus","volume":"108","author":"DeStefano","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0200","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00006454-200206000-00004","article-title":"Childhood vaccinations and risk of asthma","volume":"21","author":"DeStefano","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0205","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archneur.60.4.504","article-title":"Vaccinations and risk of central nervous system demyelinating diseases in adults","volume":"60","author":"DeStefano","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0210","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0215","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archpedi.158.11.1031","article-title":"Safety of the trivalent inactivated influenza vaccine among children: a population-based study","volume":"158","author":"France","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0220","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/01.inf.0000130953.08946.d0","article-title":"Lack of association between hepatitis B birth immunization and neonatal death: a population-based study from the Vaccine Safety Datalink project","volume":"23","author":"Eriksen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0225","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1001\/jama.296.16.1990","article-title":"Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old","volume":"296","author":"Hambidge","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0230","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/01.inf.0000234067.84848.e1","article-title":"Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case\u2013control study","volume":"25","author":"Ray","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0235","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/pds.1354","article-title":"vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study","volume":"16","author":"Yu","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0240","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1542\/peds.2007-1578","article-title":"Risk of immune thrombocytopenic purpura after measles\u2013mumps\u2013rubella immunization in children","volume":"121","author":"France","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0245","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1542\/peds.2008-2384","article-title":"Varicella vaccination and ischemic stroke in children: is there an association?","volume":"123","author":"Donahue","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0250","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1016\/j.vaccine.2009.09.023","article-title":"Risk of immune hemolytic anemia in children following immunization","volume":"27","author":"Naleway","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0255","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2334-9-165","article-title":"Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study","volume":"9","author":"Jackson","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0260","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1542\/peds.2009-3195","article-title":"Hen\u00f6ch-Schonlein purpura and polysaccharide meningococcal vaccine","volume":"126","author":"Goodman","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0265","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1016\/j.vaccine.2011.06.112","article-title":"Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15\u201359 years of age","volume":"29","author":"Ray","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0270","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1542\/peds.2011-1294","article-title":"Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children","volume":"129","author":"Hambidge","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0275","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/aje\/kws195","article-title":"Risk of confirmed Guillain\u2013Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink project, 2009\u20132010","volume":"175","author":"Greene","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0280","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1311738","article-title":"Risk of intussusception after monovalent rotavirus vaccination","volume":"370","author":"Weintraub","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0285","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/pds.3575","article-title":"Absence of associations between influenza vaccines and increased risks of seizures, Guillain\u2013Barr\u00e9 syndrome, encephalitis, or anaphylaxis in the 2012\u20132013 season","volume":"23","author":"Kawai","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7326\/0003-4819-150-1-200901060-00009","article-title":"Advisory Committee on Immunization Practices, Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices","volume":"150","author":"Smith","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0295","series-title":"Vaccine safety research, data access, and public trust","author":"Institute of Medicine","year":"2005"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0300","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jns.2008.04.002","article-title":"Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink","volume":"271","author":"Young","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0305","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1016\/j.vaccine.2011.05.003","article-title":"Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza","volume":"29","author":"McCarthy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0310","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ajic.2005.03.016","article-title":"Where adults reported receiving influenza vaccination in the United States","volume":"33","author":"Singleton","year":"2005","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0315","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jech.56.12.951","article-title":"Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications","volume":"56","author":"Hak","year":"2002","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0320","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jclinepi.2005.11.012","article-title":"Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations","volume":"59","author":"Glanz","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0325","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.vaccine.2004.01.017","article-title":"Control without separate controls: evaluation of vaccine safety using case-only methods","volume":"22","author":"Farrington","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0330","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7812\/TPP\/12-031","article-title":"Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data","volume":"16","author":"Koebnick","year":"2012","journal-title":"Perm J"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pds.2311","article-title":"The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety","volume":"21 (Suppl. 1)","author":"Robb","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0340","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1586\/erv.10.20","article-title":"Monitoring and assessing vaccine safety: a European perspective","volume":"9","author":"Lopalco","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.07.073_bib0345","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/joim.12159","article-title":"Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?","volume":"275","author":"Trifiro","year":"2014","journal-title":"J Intern Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14010251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14010251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T19:20:21Z","timestamp":1649877621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14010251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":69,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14010251"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}